Adina F. Turcu

Adina F. Turcu

Auto-generated profile, based on publicly available information

Adina F. Turcu

Division of Metabolism, Endocrinology, and Diabetes, University of Michigan , Ann Arbor, MI 48109

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
ATAdina F. Turcu
Adina F. Turcu
JRJuilee Rege
Juilee Rege
RARichard J. Auchus
Richard J. Auchus
WRWilliam E. Rainey
William E. Rainey

31 August 2022 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
PDF file
ATAdina F. Turcu
Adina F. Turcu
JYJun Yang
Jun Yang
AVAnand Vaidya
Anand Vaidya

8 February 2019 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
ANAya T Nanba
Aya T Nanba
JRJuilee Rege
Juilee Rege
JRJianwei Ren
Jianwei Ren
RARichard J Auchus
Richard J Auchus
WRWilliam E Rainey
William E Rainey
ATAdina F Turcu
Adina F Turcu
Context The ovaries and adrenals are sources of androgens in women. While dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and testosterone (T) all decline with age, these C19 steroids correlate poorly with parameters of androgen action in postmenopausal women. Objective To comprehensively compare androgen profiles in pre- and post-menopausal women. Methods We quantified 19 steroids, including DHEA, DHEAS, T, androstenedione (A4), and the adrenal-specific 11-oxygenated C19 steroids (11oxyandrogens) 11β-hydroxytestosterone (11OHT), 11-ketotestosterone (11KT), 11β-hydroxyandrostenedione (11OHA4) and 11-ketoandrostenedione (11KA4) using liquid chromatography-tandem mass spectrometry in morning serum obtained from 100 pre- (age 20-40 years) and 100 post-menopausal (age ≥ 60 years) women. Double immunofluorescence of 3β-hydroxysteroid dehydrogenase type 2 (HSD3B2) with either cytochrome b5 (CYB5A) or sulfotransferase 2A1 (SULT2A1) was performed in normal adrenal glands obtained from 8 pre- and 8 post-menopausal women. Results DHEA, DHEAS, A4 and T were significantly higher in pre- vs. post-menopausal women (fold pre/post 2.9, 2.8, 2.9 and 1.6, respectively, p < 0.0001). In contrast, the 11-oxyandrogens did not decrease with aging, and the 11OHT/T and 11OHA4/A4 ratios showed strong positive correlations with age (r, 0.5 and 0.8, respectively, p < 0.0001). Double immunofluorescence analysis showed that, with the involution of the zona reticularis in the old adrenals, the sharp zonal segregation of HSD3B2 and CYB5A becomes less distinct, and areas of HSD3B2 and CYB5A overlap are observed. Conclusions Unlike DHEA, DHEAS, A4 and T, the 11oxyandrogens do not decline in aging women. Structural changes within the adrenal cortex might explain the evolution of androgen profiles in aging women.

8 August 2017 in Clinical Endocrinology
Verified
Journal Article
Open access
PDF file
ANAya T. Nanba
Aya T. Nanba
KNKazutaka Nanba
Kazutaka Nanba
JBJames B. Byrd
James B. Byrd
JSJames J. Shields
James J. Shields
TGThomas J. Giordano
Thomas J. Giordano
ATAdina F. Turcu
Adina F. Turcu
Summary: Objective: Correct subtyping of primary aldosteronism (PA) is essential for good surgical outcomes. Adrenal vein sampling (AVS) and/or computed tomography (CT) are used for PA subclassification. Clinical and/or biochemical improvement after surgery, however, is not always achieved in patients with presumed unilateral PA. We aimed to identify the pitfalls in PA subclassification leading to surgical treatment failures.Patients and Design: We retrospectively studied 208 patients who underwent adrenal vein sampling (AVS) for PA subclassification in a tertiary referral centre, between January 2009 and August 2016. Simultaneous bilateral AVS was performed before and after cosyntropin administration. We implemented immunohistochemistry for aldosterone synthase (CYP11B2) and 17α‐hydroxylase/17,20 lyase (CYP17A1) in adrenal glands resected from patients without improvement of PA after surgical treatment and from those with limitations in AVS interpretation.Results: Of 55 patients who underwent adrenalectomy, three (5.5%) had no improvement of PA. All three patients underwent partial adrenalectomy to remove a CT‐detected nodule present on the same side with AVS lateralization. Immunohistochemistry revealed a CYP11B2‐negative nodule in both cases available. All patients who underwent total adrenalectomy based on AVS lateralization benefitted from surgery, including three patients with unilateral unsuccessful AVS and aldosterone suppression in the catheterized side vs inferior vena cava.Conclusions: Radiographically identified adrenal nodules are not always a source of PA, even when ipsilateral with AVS lateralization. These data caution against reliance on imaging findings, either alone or in conjunction with AVS, to guide surgery for PA.

1 August 2020 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
ADAngela Davio
Angela Davio
HWHelen Woolcock
Helen Woolcock
ANAya T Nanba
Aya T Nanba
JRJuilee Rege
Juilee Rege
POPatrick O’dAy
Patrick O’dAy
ATAdina F Turcu
Adina F Turcu
Context The gonads are the major source of sex steroids during reproductive ages. The gonadal function declines abruptly in women and gradually in men. The adrenals produce 11-oxygenated androgens (11-oxyandrogens), which start rising during adrenarche. Following menopause, 11-oxyandrogens levels remain similar to reproductive ages. Objective To compare the circulating 11-oxyandrogen concentrations in men and women across adult ages. Methods We used mass spectrometry to measure testosterone (T), androstenedione (A4), 11β-hydroxytestosterone (11OHT), 11-ketotestosterone (11KT), 11β-hydroxyandrostenedione (11OHA4), 11-ketoandrostenedione (11KA4), cortisol, and cortisone in morning sera obtained from adults in outpatient setting. We performed double immunofluorescence of 3β-hydroxysteroid dehydrogenase type 2 and cytochrome b5 in adrenal tissue from 19 men, age 23–78 years. Results We included 590 patients (319 men), aged 18 to 97 years, and 84% white. 11KT and 11KA4 were stable across ages in women, but they declined in men (0.21 and 0.06 ng/dL/year, respectively; P < 0.05). 11OHA4 and 11OHT increased modestly with age in women (0.6 and 0.09 ng/dL/year, respectively; P < 0.01), and both remained stable across ages in men. As body mass index (BMI) increased, 11KA4 decreased in women, and 11KT increased in men, both suggesting higher 17β-hydroxysteroid dehydrogenase activity in obese individuals. A4 and T declined with age and A4 with BMI in both sexes; T declined with BMI in men. Adrenal androgenic enzyme expressions in aging men were similar to those observed in women. Conclusions In contrast with traditional androgens, the production of 11OHA4 and 11OHT is sustained with aging in both sexes. The bioactive androgen 11KT declines in aging men but not in women.

1 January 2020 in Hypertension
Verified
Journal Article
Closed access
PDF file
ATAdina F. Turcu
Adina F. Turcu
TWTaweesak Wannachalee
Taweesak Wannachalee
ATAlexander Tsodikov
Alexander Tsodikov
ANAya T. Nanba
Aya T. Nanba
JRJianwei Ren
Jianwei Ren
RARichard J. Auchus
Richard J. Auchus
Adrenal vein sampling (AVS) is required to distinguish unilateral from bilateral aldosterone sources in primary aldosteronism (PA), and cortisol is used for AVS data interpretation, but cortisol has several pitfalls. In this study, we present the utility of several other steroids in PA subtyping, both during AVS, as well as in peripheral serum. We included patients with PA who underwent AVS at University of Michigan between 2012 and 2018. We used mass spectrometry to simultaneously quantify 17 steroids in adrenal veins (AV) and periphery, both at baseline and after cosyntropin administration. PA was classified as unilateral or bilateral based on a lateralization index ≥ or <4, respectively, separately for baseline and post-cosyntropin administration. Of 131 participants, AV catheterizations was deemed failed in 28 (21 %) patients (36 AVs) at baseline. Eight steroids demonstrated higher AV/periphery ratios than cortisol ( P <0.01 for all); 11β-hydroxyandrostenedione, 11-deoxycortisol, and corticosterone rescued most failed baseline catheterizations. Lateralization was generally consistent when using these alternative steroids. Based on pre- and post-cosyntropin data, the remaining 103 patients were classified as: U/U, 37; B/B, 32; U/B, 20; B/U, 14. Discriminant analysis of multi-steroid panels from peripheral serum showed distinct profiles across the 4 groups, with highest aldosterone, 18-oxocortisol and 11-deoxycorticosterone in U/U patients. In conclusion, 11β-hydroxyandrostenedione and 11-deoxycortisol are superior to cortisol for AVS data interpretation. Single assay multi-steroid panels measured in peripheral serum are helpful in stratified PA subtyping and have the potential to circumvent AVS in a subset of patients with PA.